Business Case

Assessed the burden of inherited retina diseases to provide several emerging markets with policy-informing data and financial models to raise awareness of the burden of these diseases

A large, multi-national pharmaceutical company sought to reverse a trend of adverse policy decisions in Brazil and Mexico. LSC performed a comprehensive study to inform the markets of the cost of illness and burden of inherited retinal diseases, culminating in publication of findings and informing future policy decisions in the inherited retinal disease space.